| 000 | 01685 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513050533.0 | ||
| 264 | 0 | _c19950413 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI117780 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZahedi, R | |
| 245 | 0 | 0 |
_aUnique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cMar 1995 |
||
| 300 |
_a1299-305 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAngioedema _xclassification |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aComplement C1 Inactivator Proteins _xgenetics |
| 650 | 0 | 4 |
_aEndopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aGenes, Dominant _xgenetics |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Denaturation |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 |
_aTrypsin _xmetabolism |
| 700 | 1 | _aBissler, J J | |
| 700 | 1 | _aDavis, A E | |
| 700 | 1 | _aAndreadis, C | |
| 700 | 1 | _aWisnieski, J J | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 95 _gno. 3 _gp. 1299-305 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI117780 _zAvailable from publisher's website |
| 999 |
_c7883312 _d7883312 |
||